Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03230578
Other study ID # 17-237
Secondary ID
Status Completed
Phase
First received
Last updated
Start date November 14, 2017
Est. completion date June 8, 2018

Study information

Verified date October 2018
Source University of New Mexico
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The goal of this study is to identify the thoughts and perceptions of pharmacy access to hormonal contraception among rural women and pharmacists. This will be key in order to address concerns or perceived barriers in order to inform the implementation of this program.


Description:

There are no studies examining New Mexico pharmacists' interest in prescribing hormonal contraceptives or rural New Mexican women's support for pharmacist prescribed hormonal contraceptives. However, some states where pharmacists already prescribe contraception have experienced difficulties in implementing the education, infrastructure, and financial support necessary to provide hormonal contraception in the community pharmacy setting. Nationwide, 68% of women reported that they would utilize pharmacist prescribed hormonal contraception and cited benefits such as convenient hours and locations of pharmacies. The goal of this study is to identify the thoughts and perceptions of pharmacy access to hormonal contraception among rural women and pharmacists. This will be key in order to address concerns or perceived barriers in order to inform the implementation of this program.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date June 8, 2018
Est. primary completion date June 8, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria:

- Pharmacists: actively employed and currently licensed and working in rural counties in New Mexico.

- Women: Reproductive age, 18-45 years old from rural counties in New Mexico and who are fluent in English.

Exclusion Criteria:

- Pharmacists: decline to participate or work outside the defined rural areas, not currently employed or licensed.

- Women: younger than 18 or older than 45, living in urban areas (Albuquerque and Las Cruces).

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Pharmacists & women's perspectives on pharmacist prescribed hormonal contraception
The goal of this study is to identify the thoughts and perceptions of pharmacy access to hormonal contraception among rural women and pharmacists. This will be key in order to address concerns or perceived barriers in order to inform the implementation of this program.

Locations

Country Name City State
United States Eve Espey Albuquerque New Mexico

Sponsors (1)

Lead Sponsor Collaborator
University of New Mexico

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Pharmacist interview objective To explore pharmacist perspectives on providing prescriptions for hormonal contraceptives, specifically identifying perceived barriers and facilitators to implementation. 8/1/17-7/16/18
Primary Women interview objective 1.2. To explore women's perspectives on receiving hormonal contraception prescribed by pharmacists. 8/1/17-7/16/18
Primary Hypothesis to be tested Rural women and pharmacists across New Mexico will be supportive of prescriptive authority and pharmacy access to hormonal contraceptives. 8/1/17-7/16/18
See also
  Status Clinical Trial Phase
Completed NCT02577601 - Impact of Combined Hormonal Contraceptives on UPA Phase 4
Completed NCT03153644 - Improving Contraceptive Care for Women With Medical Conditions
Completed NCT04112095 - Adherence With Continuous-dose Oral Contraceptive: Evaluation of Self-Selection and Use Phase 3
Recruiting NCT05521646 - Implementing Best Practice Postpartum Contraceptive Services Through a Quality Improvement Initiative N/A
Active, not recruiting NCT04291001 - Ovarian Function With ENG Implant and UPA Use Early Phase 1
Completed NCT04568980 - Assessment of Contraceptive Safety and Effectiveness in Cystic Fibrosis
Completed NCT03438682 - Real World Effectiveness and Safety of Hysteroscopic (Essure®) Compared to Laparoscopic Sterilization
Active, not recruiting NCT01948882 - Evaluation of Safety and Effectiveness of the Essure (Model ESS505) Device to Prevent Pregnancy in Women N/A
Enrolling by invitation NCT04997499 - Adolescent Subcutaneous (SQ) Injection Video Validation N/A
Recruiting NCT03589040 - Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant Phase 2
Completed NCT04463680 - Rifampin and the Contraceptive Implant Phase 4
Completed NCT03154125 - Sayana® Press Extension Study Phase 3
Withdrawn NCT03725358 - A Cluster-RCT to Increase the Uptake of LARCs Among Adolescent Females and Young Women in Cameroon. N/A
Completed NCT02957630 - "E4/DRSP Endocrine Function, Metabolic Control and Hemostasis Study" Phase 1/Phase 2
Completed NCT02456584 - Pharmacodynamics and Pharmacokinetics Study of Existing DMPA Contraceptive Methods Phase 1
Completed NCT02718222 - Impact and Performance of Institutionalizing Immediate Post-partum IUD Services N/A
Recruiting NCT02121067 - LNG-IUS at 2 Weeks Postpartum Phase 4
Terminated NCT02169869 - Immediate Postplacental IUD Insertion N/A
Recruiting NCT02292056 - Medication Safety and Contraceptive Counseling for Reproductive Aged Women With Psychiatric Conditions N/A
Withdrawn NCT01930994 - Kenya Sino-implant (II) PK Study N/A